Literature DB >> 21961579

Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues.

Bagganahalli S Somashekar1, Pachiyappan Kamarajan, Theodora Danciu, Yvonne L Kapila, Arul M Chinnaiyan, Thekkelnaycke M Rajendiran, Ayyalusamy Ramamoorthy.   

Abstract

High-resolution magic-angle spinning (HR-MAS) proton NMR spectroscopy is used to explore the metabolic signatures of head and neck squamous cell carcinoma (HNSCC) which included matched normal adjacent tissue (NAT) and tumor originating from tongue, lip, larynx and oral cavity, and associated lymph-node metastatic (LN-Met) tissues. A total of 43 tissues (18 NAT, 18 Tumor and 7 LN-Met) from 22 HNSCC patients were analyzed. Principal Component Analysis of NMR data showed a clear classification between NAT and tumor tissues, however, LN-Met tissues were classified among tumor. A partial least-squares discriminant analysis model generated from NMR metabolic profiles was used to differentiate normal from tumor samples (Q(2) > 0.80, Receiver Operator Characteristic area under the curve >0.86, using 7-fold cross validation). HNSCC and LN-Met tissues showed elevated levels of lactate, amino acids including leucine, isoleucine, valine, alanine, glutamine, glutamate, aspartate, glycine, phenylalanine and tyrosine, choline containing compounds, creatine, taurine, glutathione, and decreased levels of triglycerides. These elevated metabolites were associated with highly active glycolysis, increased amino acids influx (anaplerosis) into the TCA cycle, altered energy metabolism, membrane choline phospholipid metabolism, and oxidative and osmotic defense mechanisms. Moreover, decreased levels of triglycerides may indicate lipolysis followed by β-oxidation of fatty acids that may exist to deliver bioenergy for rapid tumor cell proliferation and growth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21961579      PMCID: PMC3208743          DOI: 10.1021/pr200800w

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  67 in total

1.  1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components.

Authors:  F G Lehnhardt; G Röhn; R I Ernestus; M Grüne; M Hoehn
Journal:  NMR Biomed       Date:  2001-08       Impact factor: 4.044

2.  The oxidation of leucine in tumour-bearing rats.

Authors:  J M Argilés; F J López-Soriano
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

Review 3.  Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.

Authors:  Kristine Glunde; Natalie J Serkova
Journal:  Pharmacogenomics       Date:  2006-10       Impact factor: 2.533

4.  Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients.

Authors:  I M El Agouza; S S Eissa; M M El Houseini; Dalia E El-Nashar; O M Abd El Hameed
Journal:  Angiogenesis       Date:  2011-05-08       Impact factor: 9.596

5.  KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma.

Authors:  T Jiffar; T Yilmaz; J Lee; E Hanna; A El-Naggar; D Yu; J N Myers; M E Kupferman
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

6.  Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of human brain tumor biopsies.

Authors:  R J Maxwell; I Martínez-Pérez; S Cerdán; M E Cabañas; C Arús; A Moreno; A Capdevila; E Ferrer; F Bartomeus; A Aparicio; G Conesa; J M Roda; F Carceller; J M Pascual; S L Howells; R Mazucco; J R Griffiths
Journal:  Magn Reson Med       Date:  1998-06       Impact factor: 4.668

7.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

8.  Toward improved grading of malignancy in oligodendrogliomas using metabolomics.

Authors:  G Erb; K Elbayed; M Piotto; J Raya; A Neuville; M Mohr; D Maitrot; P Kehrli; I J Namer
Journal:  Magn Reson Med       Date:  2008-05       Impact factor: 4.668

9.  In vitro characterization of lung cancers by the use of 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis.

Authors:  H Hanaoka; Y Yoshioka; I Ito; K Niitu; N Yasuda
Journal:  Magn Reson Med       Date:  1993-04       Impact factor: 4.668

Review 10.  ROS stress in cancer cells and therapeutic implications.

Authors:  Helene Pelicano; Dennis Carney; Peng Huang
Journal:  Drug Resist Updat       Date:  2004-04       Impact factor: 18.500

View more
  30 in total

1.  Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.

Authors:  Pratima Tripathi; Pachiyappan Kamarajan; Bagganahalli S Somashekar; Neil MacKinnon; Arul M Chinnaiyan; Yvonne L Kapila; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  Int J Biochem Cell Biol       Date:  2012-06-26       Impact factor: 5.085

2.  Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics.

Authors:  Patrick-Denis St-Coeur; Julie J Poitras; Miroslava Cuperlovic-Culf; Mohamed Touaibia; Pier Morin
Journal:  J Neurooncol       Date:  2015-08-28       Impact factor: 4.130

3.  Energy metabolism in a matched model of radiation resistance for head and neck squamous cell cancer.

Authors:  Jade Mims; Nidhi Bansal; Manish S Bharadwaj; Xiaofei Chen; Anthony J Molina; Allen W Tsang; Cristina M Furdui
Journal:  Radiat Res       Date:  2015-03-04       Impact factor: 2.841

4.  Head and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde Dehydrogenase.

Authors:  Pachiyappan Kamarajan; Thekkelnaycke M Rajendiran; Jason Kinchen; Mercedes Bermúdez; Theodora Danciu; Yvonne L Kapila
Journal:  J Proteome Res       Date:  2017-02-16       Impact factor: 4.466

5.  Metabolomics of Oral/Head and Neck Cancer.

Authors:  Gaofei Yin; Junwei Huang; Wei Guo; Zhigang Huang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  NMR-Based Metabolomics in Cancer Research.

Authors:  Rui Hu; Tao Li; Yunhuang Yang; Yuan Tian; Limin Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Glutathione levels in human tumors.

Authors:  Michael P Gamcsik; Mohit S Kasibhatla; Stephanie D Teeter; O Michael Colvin
Journal:  Biomarkers       Date:  2012-08-20       Impact factor: 2.658

Review 8.  Metabolomics study of oral cancers.

Authors:  Xun Chen; Dongsheng Yu
Journal:  Metabolomics       Date:  2019-02-08       Impact factor: 4.290

9.  HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.

Authors:  Pratima Tripathi; Bagganahalli S Somashekar; M Ponnusamy; Amy Gursky; Stephen Dailey; Priya Kunju; Cheryl T Lee; Arul M Chinnaiyan; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  J Proteome Res       Date:  2013-06-18       Impact factor: 4.466

10.  Metabolomics reveals that tumor xenografts induce liver dysfunction.

Authors:  Fei Li; Andrew D Patterson; Kristopher W Krausz; Changtao Jiang; Huichang Bi; Anastasia L Sowers; John A Cook; James B Mitchell; Frank J Gonzalez
Journal:  Mol Cell Proteomics       Date:  2013-05-01       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.